371 related articles for article (PubMed ID: 10519161)
1. The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.
Chen HH; Burnett JC
Proc Assoc Am Physicians; 1999; 111(5):406-16. PubMed ID: 10519161
[TBL] [Abstract][Full Text] [Related]
2. Natriuretic peptides in the pathophysiology of congestive heart failure.
Chen HH; Burnett JC
Curr Cardiol Rep; 2000 May; 2(3):198-205. PubMed ID: 10980893
[TBL] [Abstract][Full Text] [Related]
3. Brain natriuretic peptide: role in cardiovascular and volume homeostasis.
Dhingra H; Roongsritong C; Kurtzman NA
Semin Nephrol; 2002 Sep; 22(5):423-37. PubMed ID: 12224050
[TBL] [Abstract][Full Text] [Related]
4. The renal and cardiovascular effects of natriuretic peptides.
Wong PC; Guo J; Zhang A
Adv Physiol Educ; 2017 Jun; 41(2):179-185. PubMed ID: 28377431
[TBL] [Abstract][Full Text] [Related]
5. Natriuretic peptides and their therapeutic potential.
Cho Y; Somer BG; Amatya A
Heart Dis; 1999; 1(5):305-28. PubMed ID: 11720638
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart.
Dickey DM; Flora DR; Bryan PM; Xu X; Chen Y; Potter LR
Endocrinology; 2007 Jul; 148(7):3518-22. PubMed ID: 17412809
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in natriuretic peptides in congestive heart failure.
Boerrigter G; Burnett JC
Expert Opin Investig Drugs; 2004 Jun; 13(6):643-52. PubMed ID: 15174950
[TBL] [Abstract][Full Text] [Related]
8. Maximizing the natriuretic peptide system in experimental heart failure: subcutaneous brain natriuretic peptide and acute vasopeptidase inhibition.
Chen HH; Lainchbury JG; Harty GJ; Burnett JC
Circulation; 2002 Feb; 105(8):999-1003. PubMed ID: 11864932
[TBL] [Abstract][Full Text] [Related]
9. [Atrial natriuretic peptides: diagnostic and therapeutic potential].
Brockhoff C; Warnholtz A; Münzel T
Ther Umsch; 2000 May; 57(5):305-12. PubMed ID: 10859990
[TBL] [Abstract][Full Text] [Related]
10. Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy.
Díez J
Eur J Heart Fail; 2017 Feb; 19(2):167-176. PubMed ID: 27766748
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptides and therapeutic applications.
Lee CY; Burnett JC
Heart Fail Rev; 2007 Jun; 12(2):131-42. PubMed ID: 17440808
[TBL] [Abstract][Full Text] [Related]
12. Differential expression and synthesis of natriuretic peptides determines natriuretic peptide receptor expression in primary cultures of human proximal tubular cells.
Mistry SK; Hawksworth GM; Struthers AD; McLay JS
J Hypertens; 2001 Feb; 19(2):255-62. PubMed ID: 11212968
[TBL] [Abstract][Full Text] [Related]
13. Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation.
Dickey DM; Potter LR
J Mol Cell Cardiol; 2011 Jul; 51(1):67-71. PubMed ID: 21459096
[TBL] [Abstract][Full Text] [Related]
14. Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides.
Ichiki T; Huntley BK; Sangaralingham SJ; Burnett JC
JACC Heart Fail; 2015 Sep; 3(9):715-23. PubMed ID: 26362447
[TBL] [Abstract][Full Text] [Related]
15. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
[TBL] [Abstract][Full Text] [Related]
16. Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides.
Nishikimi T; Kuwahara K; Nakao K
J Cardiol; 2011 Mar; 57(2):131-40. PubMed ID: 21296556
[TBL] [Abstract][Full Text] [Related]
17. Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle.
Moltzau LR; Aronsen JM; Meier S; Skogestad J; Ørstavik Ø; Lothe GB; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
J Pharmacol Exp Ther; 2014 Sep; 350(3):681-90. PubMed ID: 25022512
[TBL] [Abstract][Full Text] [Related]
18. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
[TBL] [Abstract][Full Text] [Related]
19. Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.
Wegner M; Ganten D; Stasch JP
Hypertens Res; 1996 Dec; 19(4):229-38. PubMed ID: 8986453
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment with neutral endopeptidase inhibitor improves cardiac function and reduces natriuretic peptides in rats with chronic heart failure.
Maki T; Nasa Y; Yamaguchi F; Yoshida H; Mori M; Takada T; Horikawa E; Okano K; Takeo S
Cardiovasc Res; 2001 Aug; 51(3):608-17. PubMed ID: 11476752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]